Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

2 results
12:00 AM, Oct 24, 2013  |  BC Innovations | Strategy

Synaptic synopsis

Depression GRIN2B (NR2B) Cerecor Inc. CERC-301 Phase I Depression NMDAR Naurex NRX-1074 Phase I Depression mGluR2
GRM2) BrainCells Inc. BCI-838 Phase I Depression AMPA glutamate receptor (GRIA; GLUR) Pfizer Inc. (NYSE:PFE) PF-04958242 …
mGluR5 Seaside Therapeutics Inc. STX110 Preclinical ASD mGluR4 (GRM4) Domain Therapeutics S.A. DT1687 Preclinical Schizophrenia mGluR2
12:00 AM, Oct 13, 2011  |  BC Innovations | Strategy

Lilly's opening moves

cancer metabolism target. Finally, Lilly is screening for allosteric metabotropic glutamate receptor subtype 2 ( mGluR2
GRM2 ) antagonists for neurological or psychiatric indications and calcitonin gene-related peptide receptor ( CGRP …